Citations Affected: Noncode.
Synopsis: Prescribing psychotropic medication for children. Requires
the controlled substances advisory committee to review the records
maintained by the central repository for controlled substances
designated by the state police department regarding the prescribing of
psychotropic medications to children. Requires the report to contain
specified information and to be filed with the legislative council,
governor, and medical licensing board by December 1, 2001.
Effective: July 1, 2001.
January 22, 2001, read first time and referred to Committee on Health and Provider
February 27, 2001, amended, reported favorably _ Do Pass.
March 5, 2001, read second time, amended, ordered engrossed.
A BILL FOR AN ACT concerning professions and occupations.
SECTION 1. [EFFECTIVE JULY 1, 2001] (a) As used in this
SECTION, "advisory committee" refers to the controlled
substances advisory committee established by IC 35-48-2-1(f).
(b) The advisory committee shall review the records maintained by the central repository for controlled substances designated by the state police department under IC 35-48-7-10 regarding the prescribing of psychotropic medications to children.
(c) Not later than December 1, 2001, the advisory committee shall submit a report to the legislative council, the governor, and the medical licensing board established under IC 25-22.5-2-1 regarding the review required under this SECTION.
(d) The report required under subsection (c) must include the following:
(1) A comparison of the number of prescriptions written for psychotropic medications for children:
(A) participating in Medicaid (IC 12-15) or the children's heath insurance program (IC 12-17.6); and
(B) not participating in a program described in clause (A).
(2) A statement by the advisory committee regarding whether the information provided under subdivision (1) indicates that psychotropic medications are being disproportionately prescribed for children described in subdivision (1)(A).
(3) Identification of any pattern of prescribing of psychotropic medications for children contrary to the most recent guidelines adopted by the American Academy of Pediatrics and the American Academy of Child and Adolescent Psychiatry.
(e) The report required under subsection (c) may not contain any information that:
(1) may be used to identify a child for whom a psychotropic medication was prescribed; or
(2) indicates that a particular physician's prescribing of psychotropic medications to a child was inappropriate.
(f) Any meeting held by the advisory committee to comply with this SECTION is not open to the public.
(g) Unless otherwise provided by law, records reviewed by the advisory committee to comply with this SECTION are not public records.
(h) This SECTION expires December 31, 2001.